David Scott Jones - 01 Nov 2021 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EYPT	Stock Option (Right to Buy)	Award	$0	+10,000		$0.000000	10,000	01 Nov 2021	Common Stock	10,000	$11.47	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months